Block listing Interim Review

RNS Number : 4049L
Advanced Medical Solutions Grp PLC
06 September 2019


6 September 2019

  Advanced Medical Solutions Group plc

(“AMS”, the “Company” or the “Group”)

 

Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), the surgical and advanced wound care specialist company, makes the following notification pursuant to Schedule Six of the AIM Rules for Companies regarding its existing block admission arrangements:

 

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1.   Deferred Share Bonus Scheme

2.   Enterprise Management Incentive Scheme

3.   Company Share Option Plan

4.   Unapproved Executive Share Option Scheme

5.   Long Term Incentive Plan

6.   Deferred Annual Bonus Scheme

Period of return:

From:

6 March 2019

To:

5 September 2019

Balance of unallotted securities under scheme(s) from previous return:

1. 795,647

2. 38,000

3. 439,808

4. 1,454,703

5. 1,224,399

6. 486,987

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 134,093

2. Nil

3. 116,075

4. 417,475

5. 448,365

6. 79,876

 

 

 

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. 661,554

2. 38,000

3. 323,733

4. 1,037,228

5. 776,034

6. 407,111

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018

 

 

Name of contact:

Eddie Johnson

Telephone number of contact:

01606 545506

 

 

For further information, please visit www.admedsol.com or contact:

 

Advanced Medical Solutions Group plc

Tel: 44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer




Consilium Strategic Communications

Tel: 44 (0) 20 3709 5700

Mary-Jane Elliott / Matthew Neal / Nicholas Brown / Olivia Manser




Investec Bank PLC – Nominated Adviser & Broker

Tel: 44 (0) 20 7597 5970

Daniel Adams / Patrick Robb / Gary Clarence


 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BLRUGUCABUPBGWA